Education
About Us
Working with TipRanks
Follow Us
Scott L Burrows Insider Profile
4 Followers
Scott L Burrows, CFO at Arcutis Biotherapeutics, holds 116.42K shares in Spyre Therapeutics (Ticker: SYRE), holds 59.12K shares in Arcutis Biotherapeutics (Ticker: ARQT). Most recently, Scott L Burrows Sold ― shares of Spyre Therapeutics on Sep 03, 2025 for an estimated value of $299.64K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+19.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott L Burrows holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 05, 2024 - Sep 05, 2025
Return:+39.30%
The most profitable trade made by Scott L Burrows
Scott L Burrows's Trading History
Arcutis Biotherapeutics
Mar 08, 2023
CFO
Uninformative Sell
4.44K
$1.02M
Spyre Therapeutics
Sep 03, 2025
CFO
Informative Sell
299.64K
$1.94M
List of latest transactions for each holding click on a transaction to see Scott L Burrows's performance on stock
You May Also Like
Scott L Burrows insider profile FAQ
What is the percentage of profitable transactions made by Scott L Burrows?
The percentage of profitable transactions made by Scott L Burrows is 50%.
What is the average return per transaction made by Scott L Burrows?
The average return per transaction made by Scott L Burrows is 19.10%.
What stocks does Scott L Burrows hold?
Scott L Burrows holds: ARQT, SYRE stocks.
What was Scott L Burrows’s latest transaction?
Scott L Burrows latest transaction was an Informative Sell of $299.64K.
What was Scott L Burrows's most profitable transaction?
Scott L Burrows’s most profitable transaction was an Informative Sell of SYRE stock on September 5, 2024. The return on the trade was 39.30%.
What is Scott L Burrows's role in Arcutis Biotherapeutics?
Scott L Burrows's role in Arcutis Biotherapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.